DE69001513T2 - Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln. - Google Patents

Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.

Info

Publication number
DE69001513T2
DE69001513T2 DE90112251T DE69001513T DE69001513T2 DE 69001513 T2 DE69001513 T2 DE 69001513T2 DE 90112251 T DE90112251 T DE 90112251T DE 69001513 T DE69001513 T DE 69001513T DE 69001513 T2 DE69001513 T2 DE 69001513T2
Authority
DE
Germany
Prior art keywords
polyoxyethylene
castor oil
soft capsules
glycol
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90112251T
Other languages
German (de)
English (en)
Other versions
DE69001513D1 (de
Inventor
Masanori Kayano
Keizo Uesugu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69001513D1 publication Critical patent/DE69001513D1/de
Publication of DE69001513T2 publication Critical patent/DE69001513T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE90112251T 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln. Expired - Fee Related DE69001513T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17732489 1989-07-10

Publications (2)

Publication Number Publication Date
DE69001513D1 DE69001513D1 (de) 1993-06-09
DE69001513T2 true DE69001513T2 (de) 1993-10-28

Family

ID=16028989

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90112251T Expired - Fee Related DE69001513T2 (de) 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.

Country Status (13)

Country Link
US (1) US5139740A (cg-RX-API-DMAC7.html)
EP (1) EP0407815B1 (cg-RX-API-DMAC7.html)
JP (1) JP3048602B2 (cg-RX-API-DMAC7.html)
KR (1) KR930000048B1 (cg-RX-API-DMAC7.html)
CN (1) CN1041600C (cg-RX-API-DMAC7.html)
AT (1) ATE88902T1 (cg-RX-API-DMAC7.html)
CA (1) CA2020261A1 (cg-RX-API-DMAC7.html)
DE (1) DE69001513T2 (cg-RX-API-DMAC7.html)
DK (1) DK0407815T3 (cg-RX-API-DMAC7.html)
ES (1) ES2055227T3 (cg-RX-API-DMAC7.html)
FI (1) FI96169C (cg-RX-API-DMAC7.html)
GR (1) GR3007793T3 (cg-RX-API-DMAC7.html)
NO (1) NO177484C (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI901046A7 (fi) * 1989-03-17 1990-09-18 Eisai Co Ltd Polyprenyyliyhdisteen stabiloiminen
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
FI991343A7 (fi) * 1996-12-12 1999-06-11 Upjohn Co Dihydropolyprenolien öljykoostumus
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
ES2445947T3 (es) 2003-08-13 2014-03-06 Biocon Limited Formulaciones para dosificación de sólidos de sales de ácidos grasos en forma de micropartículas para agentes terapéuticos
MX340951B (es) * 2011-09-29 2016-07-29 Plx Pharma Inc Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas.
EP4125820A4 (en) 2020-03-26 2024-04-10 PLx Opco Inc. Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same
WO2025219169A1 (en) 2024-04-16 2025-10-23 Bayer Consumer Care Ag Stable soft capsule preparations with liquid fill for moisture sensitive active ingredients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems

Also Published As

Publication number Publication date
CA2020261A1 (en) 1991-01-11
GR3007793T3 (cg-RX-API-DMAC7.html) 1993-08-31
EP0407815A3 (en) 1991-02-27
KR910002443A (ko) 1991-02-25
FI96169C (fi) 1996-05-27
DE69001513D1 (de) 1993-06-09
CN1041600C (zh) 1999-01-13
CN1048656A (zh) 1991-01-23
EP0407815B1 (en) 1993-05-05
JP3048602B2 (ja) 2000-06-05
JPH03128322A (ja) 1991-05-31
FI96169B (fi) 1996-02-15
ATE88902T1 (de) 1993-05-15
NO903058D0 (no) 1990-07-09
US5139740A (en) 1992-08-18
FI903030A0 (fi) 1990-06-15
EP0407815A2 (en) 1991-01-16
KR930000048B1 (ko) 1993-01-06
DK0407815T3 (da) 1993-06-01
NO903058L (no) 1991-01-11
NO177484B (no) 1995-06-19
NO177484C (no) 1995-09-27
ES2055227T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
DE69627817T2 (de) Pharmazeutische zubereitung, die fenofibrat und polyglykolisierte glyceride enthält
DE60028384T2 (de) Propofol enthaltende anästhetische zusammensetzung zur intravenösen injektion
DE4340781C3 (de) Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
DE69816335T2 (de) Cyclosporin-enthaltende mikroemulsion-vorkonzentratzusammensetzung
AT400517B (de) Topisches terbinafinpräparat und verfahren zu seiner herstellung
DE68904459T2 (de) Antacidzusammensetzungen mit laengerer verweilzeit im magen.
DE69427589T2 (de) Neue zusammensetzung
DE4219526C2 (de) Pharmazeutisches Mittel
EP1092429B1 (de) Pharmazeutische Präparate für schwerlösliche Wirkstoffe
CH680789A5 (cg-RX-API-DMAC7.html)
DE3438630A1 (de) Kombinierte fettsaeurezusammensetzung zur senkung des cholesterin- und triglycerid-blutspiegels
DE1467907C3 (de) Verfahren zur Herstellung von .Weich gelatinekapseln
CH644518A5 (de) Pharmazeutisches praeparat zur regulierung des knochenmetabolismus.
DE69427981T2 (de) Verkapselter arzneistoff
DE69525740T2 (de) Spezielle halofantrinhaltige Zusammensetzungen
DE69001513T2 (de) Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.
DE3785849T2 (de) Jod enthaltende emulsion.
DE69021289T2 (de) Angiographisches Adjuvans.
DE3540175C2 (de) Dithranolhaltige pharmazeutische Zubereitung
DE60001266T2 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
DE3884945T2 (de) Emulsion für parenterale verabreichung.
EP0651995B1 (de) Cyclosporin(e) enthaltende o/w Emulsion zur oralen Verabreichung
DE69428967T2 (de) Pharmazeutische emulsionen, die bioaktive steroide enthalten
EP1140135B1 (de) Cyclosporin-lösung
DE3042975A1 (de) Mikrodispersion mit einem wirkstoff und/oder einem reagens in salzform als disperser phase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee